Etripamil
AssetAlso MS)-MSP-2017, -MSP-2017
Blocks L-type calcium channels to slow atrioventricular conduction and reduce rapid heart rate.
- Stage
- Phase 3
- Modality
- Small molecule
- Target
- CACNA1C
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Atrial fibrillation with rapid ventricular response
Phase 3, globenewswire.com, 9 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Evidence for its targets1
- Competitors3
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.